Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response — which in severe cases can be life-threatening. A team of researchers has now identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk. The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- A quiet change in everyday foods could save thousands of lives
- Scientists may have been wrong about what causes asthma
- Alzheimer’s may trick the brain into erasing its own memories
- This new antibody may stop one of the deadliest breast cancers
- Why some people get bad colds and others don’t
- Stanford scientists found a way to regrow cartilage and stop arthritis
- A common painkiller may be quietly changing cancer risk
- Vitamin A may be helping cancer hide from the immune system
- Long COVID may be fueled by inflammation and tiny clots
- A global cancer surge is underway and the world is not ready
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
